摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(2-(4-fluoro-2-methylphenyl)thiazol-4-yl)-1H-benzo[d]imidazol-2(3H)-one | 1569065-87-7

中文名称
——
中文别名
——
英文名称
5-(2-(4-fluoro-2-methylphenyl)thiazol-4-yl)-1H-benzo[d]imidazol-2(3H)-one
英文别名
5-[2-(4-Fluoro-2-methylphenyl)-1,3-thiazol-4-yl]-1,3-dihydrobenzimidazol-2-one;5-[2-(4-fluoro-2-methylphenyl)-1,3-thiazol-4-yl]-1,3-dihydrobenzimidazol-2-one
5-(2-(4-fluoro-2-methylphenyl)thiazol-4-yl)-1H-benzo[d]imidazol-2(3H)-one化学式
CAS
1569065-87-7
化学式
C17H12FN3OS
mdl
——
分子量
325.366
InChiKey
FTJZJSPAXVCBBO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    82.3
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为产物:
    参考文献:
    名称:
    Targeting the PPM1D phenotype; 2,4-bisarylthiazoles cause highly selective apoptosis in PPM1D amplified cell-lines
    摘要:
    The metal-dependent phosphatase PPM1D (WIP1) is an important oncogene in cancer, with over-expression of the protein being associated with significantly worse clinical outcomes. In this communication we describe the discovery and optimization of novel 2,4-bisarylthiazoles that phenocopy the knockdown of PPM1D, without inhibiting its phosphatase activity. These compounds cause growth inhibition at nanomolar concentrations, induce apoptosis, activate p53 and display impressive cell-line selectivity. The results demonstrate the potential for targeting phenotypes in drug discovery when tackling challenging targets or unknown mechanisms. (C) 2014 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2014.05.067
点击查看最新优质反应信息

文献信息

  • FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE
    申请人:The Institute of Cancer Research: Royal Cancer Hospital
    公开号:US20150232462A1
    公开(公告)日:2015-08-20
    The present invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof for use in the treatment of cancer:
    本发明提供式(I)的化合物及其药学上可接受的盐,合物和溶剂化物,用于治疗癌症:
  • US9550764B2
    申请人:——
    公开号:US9550764B2
    公开(公告)日:2017-01-24
查看更多